Learning Disability Treatment Market Growth and Sales Forecast 2014 - 2020

 Pooja M
  18th-Apr-2019
 53

Learning disability is the disorder of brain to receive, store and respond to the new information. People suffering from learning disabilities have problems in listening, paying attention, reading, speaking, writing, reasoning and performing mathematical operations. Learning disability is actually a group of disorders, not a single disorder which includes dyslexia, dyscalculia, dysgraphia, dyspraxia, attention-deficit hyperactivity disorder (ADHD) and auditory and visual processing disorders. Learning disorders occurs at very young age but they are usually recognized at an early age of five years.

Currently there are no medicines available for the core treatment of learning disability as the cause is still unkown. However, there are few medicines available which are being prescribed for the treatment and management of ADHD disorder in patients with learning disability.

Obtain Report Details @ https://www.transparencymarketresearch.com/learning-disability-treatment.html

These medicines are segmented into three major categories which include:

  • Stimulants
  • Non-Stimulants
  • Other medicines

Stimulants are the psychoactive drugs which are focused on inducing temporary improvements in either mental or physical actions or both.

Request Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=2478

These are best studied and highly used medicines to treat ADHD in learning disability treatment market. Common stimulants medications include:

  • Methylphenidate (Ritalin, Concerta)
  • Dexmethylphenidate (Focalin)
  • Amphetamine/Dextroamphetamine (Adderall, Dexedrine, Dextrostat)
  • Lisdexamfetamine (Vyvanse)

Strattera is the only non-stimulant in the learning disability market, approved by the U.S. FDA for the treatment of ADHD. Other medicines which are used for learning disability treatment include:

  • Antidepressants – bupropion (Wellbutrin)
  • Tricyclics – imipramine (Tofranil), nortriptyline (Pamelor, Aventyl), desipramine (Norpramin)
  • Alpha-2 agonists – clondine (Catapres), guanfacine (Tenex)

Besides, there are certain special schools which perform special kind of therapies, to manage the patient’s condition suffering from learning disability. Learning disability therapies include social skills group, solution focused counseling and cognitive behavioral therapy. Social skills group help children learn how to initiate conversations, take turns, make and keep friends and regulate their emotions. According to National Center for Learning Disabilities, 75% of the kids suffering from local disability suffer from problems associated with social skills. Besides, cognitive behavioral therapy is focused on helping the child understand how thoughts of a person affect one’s feelings and behavior. Above all these therapies, it is most essential that parents should handle their child, who is suffering from this disorder, with excessive care and patience.

Request for TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=2478

North America and Europe leads the learning disability treatment market with respect to the medication of ADHD and number of special schools for learning disability children. The U.S. Department of Education has established the law by the name “The Individuals with Disabilities Education Act (IDEA)”, which provides services to learning, disable individuals through its programs. Foundation for people with learning disabilities has also been established in the U.K., which deals with the patient concerns, conduct surveys, awareness programs and research and development activities in context to learning disability. Asia-Pacific is growing faster for learning disability treatment market majorly due to increasing government and private sector initiatives to set up special schools and to spread awareness about the available medicines.

As for instance, Association of Learning Disabilities of India is working in association with Indian Association of Pediatrics, to improve the conditions of special schools and to spread awareness about the medications available. The major market players which manufacture ADHD medications for learning disability treatment include Pfizer, Inc., Forest Laboratories, Inc., Eli Lilly and Company, Novartis AG and Shire Plc.

Domain: Business
Category: Sales & Marketing
Posted By: Pooja M and Contact Pooja M

Recent Press Releases

What Are Benefits Of Oceans?

Oceans are loved by people as it provides lots of benefits to people. People not only enjoy over there but also enjoy lots of health benefits. Visiting oceans is best for people su

17 September, 2019

Polyurethane Elastomers Market is Ex...

The report “Polyurethane Elastomers Market by Type (Thermoset Polyurethane Elastomers and TPU Elastomers), Application (Footwear, Automotive & Transportation, Industrial

17 September, 2019

IVF Equipment Market Size & Share | ...

Growth of this market include growth in the median age of first-time motherhood, declining fertility rates, rising male infertility, rise in consumption of alcohol and cigarettes,

17 September, 2019